The University of Pittsburgh granted Stemline exclusive worldwide rights to a cancer vaccine SL-701

University of Pittsburgh

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Stemline Therapeutics Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced